This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1pl0

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1pl0.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1pl0.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1pl0| PDB=1pl0 | SCENE= }}
{{STRUCTURE_1pl0| PDB=1pl0 | SCENE= }}
-
'''Crystal structure of human ATIC in complex with folate-based inhibitor, BW2315U89UC'''
+
===Crystal structure of human ATIC in complex with folate-based inhibitor, BW2315U89UC===
-
==Overview==
+
<!--
-
Aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase/IMP cyclohydrolase (ATIC) is a bifunctional enzyme with folate-dependent AICAR transformylase and IMP cyclohydrolase activities that catalyzes the last two steps of purine biosynthesis. The AICAR transformylase inhibitors BW1540 and BW2315 are sulfamido-bridged 5,8-dideazafolate analogs with remarkably potent K(i) values of 8 and 6 nm, respectively, compared with most other antifolates. Crystal structures of ATIC at 2.55 and 2.60 A with each inhibitor, in the presence of substrate AICAR, revealed that the sulfonyl groups dominate inhibitor binding and orientation through interaction with the proposed oxyanion hole. These agents then appear to mimic the anionic transition state and now implicate Asn(431') in the reaction mechanism along with previously identified key catalytic residues Lys(266) and His(267). Potent and selective inhibition of the AICAR transformylase active site, compared with other folate-dependent enzymes, should therefore be pursued by further design of sulfonyl-containing antifolates.
+
The line below this paragraph, {{ABSTRACT_PUBMED_14966129}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 14966129 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_14966129}}
==Disease==
==Disease==
Line 37: Line 41:
[[Category: Imp cyclohydrolase]]
[[Category: Imp cyclohydrolase]]
[[Category: Xanthosine monophosphate]]
[[Category: Xanthosine monophosphate]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 05:12:19 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 11:43:32 2008''

Revision as of 08:43, 28 July 2008

Image:1pl0.png

Template:STRUCTURE 1pl0

Contents

Crystal structure of human ATIC in complex with folate-based inhibitor, BW2315U89UC

Template:ABSTRACT PUBMED 14966129

Disease

Known disease associated with this structure: AICA-ribosiduria due to ATIC deficiency OMIM:[601731]

About this Structure

1PL0 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Crystal structures of human bifunctional enzyme aminoimidazole-4-carboxamide ribonucleotide transformylase/IMP cyclohydrolase in complex with potent sulfonyl-containing antifolates., Cheong CG, Wolan DW, Greasley SE, Horton PA, Beardsley GP, Wilson IA, J Biol Chem. 2004 Apr 23;279(17):18034-45. Epub 2004 Feb 13. PMID:14966129

Page seeded by OCA on Mon Jul 28 11:43:32 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1pl0"
Personal tools